Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology
Online ISSN : 1882-2738
Print ISSN : 0914-2649
ISSN-L : 0914-2649
Epicutaneous immunotherapy
Kota Hirai
Author information
Keywords: AIT, EPIT, food allergy, OIT
JOURNAL RESTRICTED ACCESS

2021 Volume 35 Issue 1 Pages 88-93

Details
Abstract

Allergen immunotherapy is considered to be the only treatment that has the potential to improve the natural history of allergic diseases. Currently, as the routes of allergen administration, subcutaneous, oral, sublingual, and epicutaneous administration have been used. In food allergy, oral immunotherapy is widely conducted. However, because of the uncertainty for acquiring tolerance and the high risk of inducing adverse events such as anaphylaxis, it has not yet been approved as a general treatment. On the other hand, although there are several problems including efficacy, side effects, appropriate amounts of allergen, and its application, be solved in epicutaneous immunotherapy, it has been recently accepted as a relatively safe method. In this review, I will show the recent information for epicutaneous immunotherapy as well as our own results.

Content from these authors
© 2021 Japanese Society of Pediatric Allergy and Clinical Immunology
Previous article Next article
feedback
Top